Y-mAbs Therapeutics is the subject of a securities class action settlement with a total fund of $19,650,000.00, covering persons or entities who purchased Y-mAbs stock between October 6, 2020 and October 28, 2022. Claimants were required to submit documentation supporting their purchases. Note that the official claim deadline of October 7, 2024 has passed; this record is preserved for reference.